The document analyzes the biomedical industry in the Mirandola district of Italy. It describes how the district specializes in biomedical devices and disposable products, with most companies being small-medium sized. Five large multinational groups control the major companies in the district, generating over 80% of revenues. The district sees increasing demand in areas like renal care and generates over 500 million euros in annual revenues, though faces threats from lack of infrastructure and potential Asian competition.